Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

By Ivins B.   Fellows P.   Pitt L.   Estep J.   Farchaus J.   Friedlander A.   Gibbs P.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1779-1784

Elsevier

Access to resources Recommend Favorite

Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin

By Gaur R.   Gupta P.K.   Banerjea A.C.   Singh Y.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2836-2839

Elsevier

Access to resources Recommend Favorite

Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii

By Kedzierski L.   Black C.G.   Stowers A.W.   Goschnick M.W.   Kaslow D.C.   Coppel R.L.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4661-4668

Elsevier

Access to resources Recommend Favorite

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y.   Inoue N.   Xuan X.   Nagasawa H.   Igarashi I.   Fujisaki K.   Otsuka H.   Mikami T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin

By Fellows P.F.   Linscott M.K.   Ivins B.E.   Pitt M.L.M.   Rossi C.A.   Gibbs P.H.   Friedlander A.M.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3241-3247

Elsevier

Access to resources Recommend Favorite